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Summary
Recent evidence demonstrates that female subjects
show exaggerated responses to 3,4-methylene-
dioxymethamphetamine (MDMA) compared with
males. The aim of our study was to evaluate sex dif-
ferences and the role of endogenous gonadal hor-
mones on the effects of MDMA. Fifty-six intact and
gonadectomized male and female Sprague-Dawley
rats were randomly assigned to either MDMA (5
mg/kg) or saline treatment. Learning and memory
were assessed using the Morris water maze (MWM).
The expression of Bax and Bcl-2 in the hippocampus
was detected by Western blotting.
Behavioral analysis showed that MDMA led to memo-
ry impairment in both male and female rats. The
female rats showed more sensitivity to impairment
than the males, as assessed using all the memory
parameters in the MWM. Ovariectomy attenuated the
MDMA-induced memory impairment. By contrast,
orchiectomized rats showed more impairment than
Sex differences in MDMA-induced toxicity in
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MDMA-treated intact male rats. Bcl-2 and Bax were
down-regulated and up-regulated in MDMA-treated
male and female rats, respectively.
MDMA treatment in the orchiectomized rats led to up-
regulation of Bax and down-regulation of Bcl-2.
Ovariectomy attenuated the MDMA-induced up-regu-
lation of Bax and caused more expression of Bcl-2
compared with what was observed in the MDMA-treat-
ed intact female rats.
In summary, female rats showed exaggerated
responses to the effects of MDMA and this may be
explained by endogenous gonadal hormones.
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Introduction
3,4-methylenedioxymethamphetamine (MDMA), also
known as ecstasy, is an illicit drug of abuse that can
cause behavioral and neurotoxic damage in humans
and animals (Ros-Simó et al., 2012; Watkins et al.,
2013). MDMA influences serotonergic, dopaminergic
and noradrenergic nerve endings in the brain, showing
greater affinity for the serotonergic system. It causes
an increase in synaptic serotonin levels and binds to
the serotonin transporter. At high doses, MDMA pro-
duces an acute depletion in serotonin in serotonergic
endings at 4-6 h followed by a recovery by 24 h
(Schmidt, 1987). MDMA also affects a-adrenergic
receptors, serotonin 5-HT2 receptors, muscarinic M1
receptors and histamine H1 receptors, with more affin-
ity for 5-HT2 receptors (Lyles and Cadet, 2003). The
neurotoxic effects of MDMA are relatively well
described in humans and animals. For example, it has
been shown that MDMA causes feelings of closeness
accompanied by enhanced emotion and increased
blood pressure, heart rate and body temperature, as
well as many other effects (Steinkellner et al., 2011).
Exposure to MDMA causes memory impairment and
cell death in many regions of the brain (Stephenson et
al., 1999; Soleimani Asl et al., 2012). However, little is
known about sex differences related to MDMA-induced
neurotoxicity. Studies in humans have described that
women report greater thought disturbances, perceptu-
al changes, and fear of loss of body control. By con-
trast, men experience greater increases in blood pres-
sure (Liechti et al., 2001). The other sex differences in
the response to ecstasy include increased subjective
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effects in females compared with males, and greater
susceptibility to the effects of the drug, more pro-
nounced depression following ecstasy use, and a
potential increase in serotonergic neurotoxicity in
association with long-term use of MDMA in women
(Liechti et al., 2001; Verheyden et al., 2002). Another
study showed greater reduction in 5-hydroxyin-
doleacetic acid levels in females than in males
(McCann et al., 1994). There are only a few studies
that have described the unequal effects of MDMA in
male and female primates. Fitzgerald et al. (1989)
reported a higher level of MDMA but not metabolic 3,4-
methylenedioxyamphetamine (MDA) in the plasma of
female rats, whereas Chu et al. (1996) showed a lower
brain concentration of MDA, but not MDMA, in female
rats after MDMA administration. Babenikova et al.
(2005) showed differences between male and female
rats in the test of prepulse inhibition of the acoustic
startle reaction, while Palenicek et al. (2005) demon-
strated high sensitivity of females to the locomotor
stimulant effects of MDMA. They observed a dose-
dependent locomotion-enhancing effect of MDMA both
in male and female rats in an elevated plus-maze; this
response was exaggerated in female rats and the
authors hypothesized that the increased sensitivity of
females to the behavioral effects of MDMA can be
explained by increased reactivity of the serotonergic
and dopaminergic systems (Palenicek et al., 2005). It
is clear that gonadal hormones affect the levels of
dopamine and serotonin in the different parts of the
brain (McEwen, 2002). It seems that the possible sex
differences in the neurotoxic effects of MDMA may be
due to gonadal hormones. To our knowledge, there is
no evidence on gender differences in MDMA-induced
memory impairment and cell death in animals or on
relations between gonadal hormones and MDMA
effects. In this study, we evaluated the sex differences
in the neurotoxic effects of MDMA and the relationship
of these effects with gonadal hormones in Sprague-
Dawley rats.
Materials and methods
Materials
MDMA was obtained from the Presidency Drug
Control Headquarters (Tehran, Iran). Other chemicals
were purchased from commercial sources.
Animals
All experiments were carried out on adult male (200-
250 g) and female (180-220 g) Sprague-Dawley rats
(Razi Institute, Iran). The animals were kept under
standard laboratory conditions (12:12 h light-dark
cycle, 50% humidity, 22±2°C, and ad libitum access to
water and food). All animal surgeries, behavioral tests
and experimental protocols were approved by the
Ethics Committee of Iran University of Medical
Sciences.
Fifty-six male and female rats were assigned as fol-
lows (n=7 per group)
1- Two saline-treated intact groups (male and female) that
received normal saline, 1 ml twice daily, IP for 7 days.
2- Two MDMA-treated intact groups (male and female)
that received MDMA, 5 mg/kg twice daily, IP for 7 days.
3- Two saline-treated gonadectomized groups (male
and female) that received normal saline, 1 ml twice
daily, IP for 7 days.
4- Two MDMA-treated gonadectomized groups (male
and female) that received MDMA, 5 mg/kg twice daily,
IP for 7 days.
Surgical procedures
One week after their arrival, the saline-treated and
MDMA-treated gonadectomized groups underwent
bilateral ovariectomy or orchiectomy to remove circu-
lating hormones.
Surgical procedures were performed under ketamine
(100 mg/kg) and xylazine (10 mg/kg) anesthesia. The
ovaries were typically approached by two separate
flank incisions and were gently pulled through the inci-
sion with a blunt forceps by grasping the fat pad sur-
rounding the instrument. A hemostat was placed at the
boundary between the oviduct and uterus, a ligature
was placed just below the hemostat (next to the uterus),
and a cut was made just above the hemostat. Once the
ovary and oviduct had been removed, the hemostat
was released and the uterus was returned to the
abdomen. Muscles and skin were closed with suture.
For orchiectomy, the testis was approached by a sin-
gle midline incision on the scrotal sac. Both testes
were pushed down into the scrotum by gentle pres-
sure on the abdomen. A hemostat was placed below
the testes and epididymis across the testicular cord
(this contains blood vessels and the vas deferens). A
ligature was placed below the hemostat and the testes
and epididymis were removed with scissors. The
hemostat was released and the incision closed in two
layers with suture.
Gonadectomy also ensured a constant level of gonadal
receptor expression within the brain because receptor
levels are regulated by hormones (Suzuki and Handa,
2005). Treatment with MDMA was begun one week
after gonadectomy (Donner and Handa, 2009).
Morris water maze
There exist various methods for measuring memory
impairments. In animals, memory impairing agents, such
as MDMA, generally impair spatial memory (Soleimani
Asl et al., 2012). In this study, therefore, we used the
Morris water maze (MWM) to evaluate spatial memory.
The MWM tank was 210 cm in diameter, 51 cm in
height, painted black, and filled to a depth of 35 cm
with water maintained at a temperature of 22±1°C.
Around the room, numerous visual cues (e.g. book-
case and tables) were present which remained con-
stant throughout the experiment. The pool was divid-
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ed into four quadrants with four starting locations -
northern (N), eastern (E), southern (S) and western
(W), each located at equal distances along the pool
rim. An invisible Plexiglas platform (10 cm diameter)
was located 1 cm below the water in the center of the
northern quadrant. The position of the escape plat-
form remained the same for all the animals across the
training trials. We trained the animals for three days at
approximately the same time (10:00-12:00 a.m.) each
day. Each training day included two blocks of four tri-
als. The time limit for each trial was 90 s. During train-
ing, the animals were allowed to swim until they locat-
ed the hidden platform or until the 90 s had elapsed.
All groups were trained from each of the starting posi-
tions (N, S, E and W). A 30 s period was allowed
between trials, which was spent on the platform. Rats
were also allowed to rest for 5 min between the two
blocks. The day after the last learning trial, each rat
was given a single 60 s probe trial and a visible trial.
The probe trials were conducted without a platform. In
the visible trials, the platform was covered with alu-
minum foil. A video camera (Nikon, Melville, NY, USA)
linked to a computer was mounted directly above the
MWM pool to record, for each rat, the time taken to
reach the hidden platform (escape latency), the length
of the swim path (distance traveled), and the percent-
age of time spent in the target quadrant.
Western blotting analysis
After the spatial memory assessment, for immunoblot-
ting of Bax and Bcl-2 proteins, three rats from each
group were killed by cervical dislocation and their hip-
pocampi were removed and immediately frozen in liq-
uid N2. The hippocampi were minced in lysis buffer,
containing RIPA buffer with a protease inhibitor cock-
tail (1:10), homogenized and centrifuged (Eppendorf,
Hamburg, Germany) at 12000 g for 20 min at a tem-
perature of 4°C. 100 μg of total proteins were dena-
tured with sample buffer (6.20 mM tris-HCL, 10% glyc-
erol, 2% SDS, 0.01% bromophenol blue and 50 mM 2-
ME) at 95°C for 5 min, then separated on a 10% sodi-
um dodecyl sulfate polyacrylamide gel for 90 min at
120 volts, and transferred to nitrocellulose membrane.
Membranes were incubated with anti Bax, anti Bcl-2,
and B-actin (1:1000; Sigma Aldrich, St. Louis, MO,
USA) for 2 h followed by alkaline phosphatase-conju-
gated secondary antibody (1:10000; Sigma Aldrich,
St. Louis, MO, USA) for 1 h. Bands were detected by
incubation with chromogenic substrate 5-bromo-4-
chloro-3-indolyl phosphate in the presence of nitrob-
lue tetrazolium. Each Western blot was performed in
triplicate.
Densitometric ratios were obtained using image analy-
sis software (UVIdoc, Houston, TX, USA).
Statistical analysis
All values are expressed as mean ± SEM. The results
of all data were statistically evaluated by two-way
analysis of variance (ANOVA) with MDMA treatment
as one factor and sex as the second factor.
Comparisons between treatment groups were con-
ducted using Tukey’s post-hoc test where appropriate.
Values of p<0.05 were considered significant.
Results
Effect of MDMA on escape latency in the Morris
water maze
A two-way ANOVA showed a significant effect of treat-
ment [F (3, 97) = 24.47, p<0.001], but not sex, on
escape latency. There was a significant interaction
between sex and MDMA treatment [F (3, 12) = 3.18,
p<0.05]. ANOVA of the three training days, showed that
the saline-treated groups spent less time in locating the
hidden platform (escape latency) than the MDMA-treat-
ed groups. Overall, MDMA significantly increased the
escape latency, when compared with saline-treated
groups, both in male and female rats (p<0.01 for males
and p<0.001 for females, Fig. 1). As shown in figure 1,
there was a significant difference between MDMA-treat-
ed female and male intact rats in the time taken to
reach the hidden platform (p<0.05). Gonadectomy in
saline-treated rats resulted in a non-significant increase
in escape latency compared with the saline-treated
intact groups. Escape latency was higher in MDMA-
treated orchiectomized rats (mean 60.89± 3.82) than
MDMA-treated intact male rats (mean 43.37±4.77).
Exposure to MDMA in ovariectomized rats led to a sig-
nificant reduction in escape latency when compared
with MDMA-treated intact females (p<0.05, Fig. 1).
There was no significant difference in escape latency in
Sex differences in ecstasy-induced toxicity
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Figure 1 - The effect of MDMA on the escape latency in the
MWM in male and female rats.
Data are expressed as mean ± SEM. Exposure to MDMA caused an
increase in escape latency in both male and female rats (a p<0.01, 
b p<0.001 vs saline-treated male group, d p<0.001 vs saline-treated female
rats). Escape latency differed significantly between female and male rats 
(c p<0.05 vs MDMA-treated male rats). Ovariectomy attenuated the escape
latency in MDMA-treated rats (e p<0.05 vs MDMA-treated intact female rats).
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the visible trial session between the treatment and
saline groups (data not shown).
Effect of MDMA on distance traveled in the Morris
water maze
A two-way ANOVA showed a significant effect of
MDMA treatment [F (3, 11) = 11.41, p<0.001], but a
non-significant effect of sex on distance traveled in the
MWM (swimming distance to the escape platform).
There was a near significant interaction between sex
and MDMA treatment [F (3, 160) = 2.51, p=0.056]. As
shown in figure 2, exposure to MDMA in the intact
groups caused a significant increase in distance trav-
eled compared with saline-treated intact rats (p<0.05
for male and p<0.001 for female rats, Fig. 2). In the
gonadectomized rats, the MDMA-treated females
demonstrated a significant increase in swimming dis-
tance to the escape platform compared with the
MDMA-treated males (p<0.001). MDMA treatment in
the ovariectomized rats caused a significant reduction
in distance traveled compared with MDMA-treated
intact female rats (p<0.05). There was no significant
difference in the distance traveled in the visible trial
session between the treatment and saline groups
(data not shown).
Effect of MDMA on time spent in the target quad-
rant in the Morris water maze
Analysis of variance of probe trials showed a signifi-
cant effect of MDMA treatment [F (3, 11) = 11.925,
p<0.001] and an insignificant effect of sex on the time
spent in the target quadrant. There was no significant
interaction between the factors. Figure 3 shows that
MDMA administration significantly decreased the time
spent in target quadrant in both male and female
intact rats (p<0.001 for males and p<0.01 for
females). MDMA-treated intact female rats spent less
time in the target quadrant compared with MDMA-
treated intact males (p<0.01). Subsequent analysis for
each sex showed that the MDMA-treated ovariec-
tomized rats spent more time in the target quadrant
(p<0.001) as compared to the MDMA-treated intact
female rats, while the MDMA-treated orchiectomized
rats spent less time in the target quadrant (mean
30.17±1.60) compared with the MDMA-treated intact
male rats (mean 32.70±2.57).
Effect of MDMA on Bax expression in the hip-
pocampus
On Western blot, anti-Bax antibody reacted specifical-
ly with 28 KD protein bands (Fig. 4). There was a sig-
nificant effect of MDMA treatment [F (3, 27) = 114.3,
p<0.001] and sex [F (1, 16) = 68.5, p<0.001] on Bax
expression in the hippocampus. A significant interac-
tion was observed between the factors sex and MDMA
treatment [F (3, 49) = 20.33, p<0.001).The intensity of
Bax was significantly enhanced in the MDMA-treated
intact rats compared with the saline-treated intact rats
(p<0.001 for males and females, Fig. 4). Bax was
more expressed in the MDMA-treated female rats
(mean 679.47±70) than male rats (mean 653.54±60)
but the difference was not significant. Gonadectomy
led to an increase in Bax expression in both the
MDMA- and saline-treated groups. The MDMA-treated
S. Soleimani et al.
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Figure 2 - The effect of MDMA on the distance traveled in the
MWM in male and female rats.
Data are expressed as mean ± SEM. MDMA treatment caused an
increase in the distance traveled (a p<0.05 and b p<0.01 vs saline-treated
male group, respectively, and c p<0.001 vs saline-treated female group).
Female rats were more sensitive than male rats (d p<0.01 vs MDMA-treat-
ed male group). MDMA-treated ovariectomized rats showed a reduction
in distance traveled (e p<0.05) as compared to MDMA-treated intact
female rats.
Figure 3 - The effect of MDMA on the time spent in the MWM
target quadrant by male and female rats.
Data are expressed as mean ± SEM. MDMA administration caused a sig-
nificant reduction in the time spent in the target quadrant in both male and
female rats (a p<0.001 and b p<0.01 vs saline-treated male and female
rats, respectively). MDMA-treated ovariectomized rats spent significantly
more time in the target quadrant (c p<0.001) as compared to the MDMA-
treated intact female rats.
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orchiectomized rats showed greater Bax expression
than did the saline-treated intact male rats (p<0.001).
Exposure to MDMA in the ovariectomized rats result-
ed in a significant reduction in Bax expression when
compared with the MDMA-treated intact rats
(p<0.001).
Effect of MDMA on Bcl-2 expression in the hip-
pocampus
Anti-Bcl-2 antibody reacted with 26 KD protein bands
(Fig. 5). A two-way ANOVA showed a significant effect
of MDMA treatment [F (3, 44) = 227.78, p<0.001] and
sex [F (1, 77) = 39.23, p<0.05] on Bcl-2 expression in
the hippocampus. A significant interaction was found
between the factors sex and MDMA treatment 
[F (3, 10) = 5.11, p<0.01]. Bcl-2 was expressed more
in the saline-treated rats. In both the male and female
intact groups, MDMA treatment caused a significant
reduction in Bcl-2 expression compared with the
saline-treated groups (p<0.001, Fig. 5). Bcl-2 was less
expressed in the MDMA-treated intact females (mean
291.96±58.63) than male rats (mean 314.54±60.10).
Gonadectomy caused a significant reduction in Bcl-2
expression compared with the values recorded in the
saline-treated intact male and female rats (p<0.001).
Bcl-2 was up-regulated in the saline-treated and
MDMA-treated ovariectomized rats compared with the
MDMA-treated intact female rats (p<0.05 for both). Discussion
In the present study, we found that the female rats, com-
pared with the male rats, were more sensitive to MDMA
toxicity and demonstrated an exaggerated response to
MDMA administration. Furthermore, MDMA induced
greater responses in orchiectomized rats compared with
non-orchiectomized rats, whereas ovariectomy attenu-
ated MDMA-induced neurotoxicity compared with what
was observed in non-ovariectomized rats.
Consistent with our study, Walker et al. (2007) showed
that MDMA elicits substantially greater locomotor acti-
vation in female rats than in male rats. Other sex dif-
ferences in the response to MDMA have previously
been reported and include increased subjective
effects in women compared with men (Liechti et al.,
2001), and more pronounced depression following
ecstasy use in women (Verheyden et al., 2002).
There is growing evidence that females are more sus-
ceptible to the effects of drugs of abuse (Carroll et al.,
2004). It has been reported that pharmacological sen-
sitivity to ecstasy is dependent on gonadal hormone
changes during the estrous cycle in female rats
(Bubenikova et al., 2005). The estrous cycle compris-
es the physiological changes that are induced by
reproductive hormones in females. Variations in
endogenous estrogen levels across the estrous cycle
modulate some aspects of memory (Warren and
Juraska, 1997).
Ovarian steroids are associated with changes in the
expression of serotonin receptors and transporters and
in serotonin metabolism; these changes result in a
higher level of serotonin available for release (Ramírez
Sex differences in ecstasy-induced toxicity
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Figure 4 - The effect of MDMA on Bax expression in the
Western blotting.
Data are expressed as mean ± SEM. Exposure to MDMA increased Bax
expression in the hippocampi of male and female rats (a and d p<0.001 vs
male and female saline-treated groups, respectively, b p<0.001 vs intact
male MDMA group). MDMA treatment in the orchiectomized rats caused
an increase in Bax expression (c p<0.05 vs saline-treated orchiectomized
rats). Saline- and MDMA-treated ovariectomized rats showed less Bax
expression (e p<0.001 vs MDMA-treated intact female rats).
Figure 5 - The effect of MDMA on Bcl-2 expression in the
Western blotting.
Data are expressed as mean ± SEM. Exposure to MDMA decreased
Bcl-2 expression in the hippocampi of male and female rats (a p<0.001
and b p<0.001 vs saline-treated male and female rats, respectively).
MDMA treatment in ovariectomized rats upregulated Bcl-2 expression
(c p<0.05 vs MDMA-treated intact female rats).
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and Carrer, 1982; McEwen, 2002). It has been estab-
lished that estrogen influences synaptic plasticity in the
hippocampus and that gonadectomy results in a loss of
post-synaptic dendritic spines of hippocampal neurons
of the CA1 region (Vedder et al., 2014). Spine density
varies with the estrous cycle, peaking at the proestrous
stage, shortly before ovulation, when serum estradiol
concentrations are highest (Woolley and McEwen,
1992). It is clear that serum levels of estradiol control
release of gonadotropin-releasing hormone (GnRH)
from the hypothalamus, which in turn stimulates the
follicle-stimulating hormone/luteinizing hormone secre-
tion that enhances the synthesis of estradiol in ovarian
granulose cells. It has been reported that GnRH recep-
tors are abundant in the hippocampus (Prange-Kiel et
al., 2008) and GnRH can also directly stimulate estra-
diol synthesis in the hippocampus, similar to its effect
on granulose cells (Brandt et al., 2013).
The mechanism by which MDMA induces greater
neurotoxicity in females is likely due to gonadal
steroid effects on the serotonergic mechanism
through which MDMA acts. A potential increase in
serotonergic neurotoxicity in association with long-
term use of MDMA has been reported in women
(Reneman et al., 2000). Fedotova and Ordyan (2010)
suggested that chronic administration of NAN-190 as
a 5-HT1A receptor antagonist in adult female rats in
the proestrous and estrous phase resulted in the
appearance of passive avoidance performance, as
distinct from the control animals. By contrast, chronic
treatment with 8-OH-DPAT as a 5-HT1A receptor ago-
nist impaired non-spatial and spatial learning in
females during all phases of the ovarian cycle. The
results of this study point to a modulatory role of
5-HT1A receptors in learning/memory processing dur-
ing the ovarian cycle in adult female rats.
Both stimulatory and inhibitory effects of MDMA on
5-HT1B and 5-HT2 receptors have been reported
(Kehne et al., 1996; Bankson and Cunningham,
2002). The enhanced response in females may
reflect a sex-specific receptor up-regulation mediat-
ed by estrogen-facilitated 5-HT2 receptor synthesis
(Kehne et al., 1996; Reneman et al., 2000; Bankson
and Cunningham, 2002).
Females exhibit increased sensitivity to the anxiolytic
effects of 5-HT1A agonists (Simerly et al., 1985), and
increased levels of basal 5-H2 function in the hip-
pocampus (Haleem et al., 1990). Also, hippocampal
levels of acetylcholine and 5-HT are consistently high-
er in female rats than in age-matched males (Hörtnagl
et al., 1993) and estradiol increases 5-HT2A receptor
density in the dorsal raphe and frontal cortex in female
rats (Sumner and Fink, 1993). It has been found that
ovarian steroids in different parts of the rat brain affect
dopamine and serotonin levels (McEwen, 2002).
In the present study, removal of the source of gonadal
hormones resulted in an increase in neurotoxicity in
male rats, whereas in female rats it attenuated
MDMA-induced spatial learning impairment and cell
death. Taken together, these findings seem to show
that gonadal hormones affect MDMA-associated neu-
rotoxicity.
Gonadectomy results in an increase in cellular 5-HT
mRNA content in the cortex, hippocampus, hypothala-
mus and amygdala, where the androgen receptors are
abundant (Simerly et al., 1990), as well as in the dor-
sal raphe nucleus. Testosterone inhibits the serotoner-
gic function that is responsible for the enhanced sero-
tonergic responsivity seen in female rats (Fischette et
al., 1984). Zhang et al. (1999) reported modulatory
effects of testosterone on serotonergic receptors at
the level of transcription or transcript processing.
Studies have shown that estradiol, a metabolite of
testosterone, modulates neuronal 5-HT content and
receptor binding as well as receptor mRNA levels
(Sumner and Fink, 1993). In female rats, estradiol has
been shown to increase 5-HT2A (but not 5-HT1A)
receptor mRNA density in multiple brain regions (Cyr
et al., 2002). Developmentally, 5-HT appears early
and exerts widespread effects on brain morphogene-
sis and synaptogenesis (Kobe et al., 2012). Gonadal
steroids may therefore alter brain morphology and
function by regulating the development of the 5-HT
system, as well as by regulating neural cell death or
apoptosis (Dodson and Gorski, 1993). Sexual dimor-
phism in brain circuitry might mediate the gender-
related differences in physiology or behavior, depend-
ing upon the brain region involved. The serotonergic
system plays a role in the regulation of affective state,
learning and memory, all of which have been demon-
strated to differ according to gender, and disturbances
of which characterize affective disorders in humans
(Price et al., 2013).
Overall, we observed impairment in spatial memory
and apoptosis following MDMA treatment both in male
and female rats. The female rats were more sensitive
to the MDMA effects than the males. The increased
sensitivity of the females can be explained by an
increased reactivity of the serotonin system due to the
effect of ovarian hormones. Understanding how
gonadal hormone-MDMA interaction affects gender
differences in the brain is essential to develop effec-
tive pharmacotherapy for both women and men.
Finally, further investigation of the sex steroids
involved in these effects appears to be necessary.
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